The findings were mixed but frequently favorable: several teleconsultation, teledermatology, telestroke, and teletherapy interventions were cost-saving or dominant, whereas home telemonitoring for chronic disease was often not cost-effective at conventional thresholds.
Evidence supports workplace interventions as part of health workforce strategies, but return on investment should not be used as a stand-alone decision criterion.
P. Catalfo, C. Cantarella, Daniele Virgillito et al.· Public Health Reviews· 0 citations
PURPOSE
Genetic counseling (GC) is integral to personalized medicine, yet detailed estimates of its cost remain limited despite growing demand. This study systematically reviewed and synthesized evidence on GC costs, examined variations across settings, methodologies, and reported cost components.
METHODS
A systemati...
Varinder Jeet, Julie Cigrang, A. Willis et al.· Genetics in Medicine· 0 citations
In recent years, the growing demand for cost-effective rehabilitation after stroke has motivated the development of novel technologies to support high-intensity rehabilitation. However, available knowledge on the economic benefits of stroke technology-assisted rehabilitation (TAR) is relatively scarce and fragmen...
Tengiz Samkharadze, O. Lambercy, R. Gassert et al.· BMC Health Services Research· 0 citations
AI in healthcare, particularly in screening and early diagnosis, shows promising cost-effectiveness, however, the strength of current evidence is moderate and highly context-dependent, and the results are sensitive to methodological assumptions, implementation costs, and healthcare system characteristics.
Ali Imani, Elham Monaghesh· Health Informatics Journal· 0 citations
An updated systematic review and meta-analysis of randomised controlled trials evaluating exercise-based CR in LMICs indicates that exercise-based CR in LMICs improves exercise capacity and HRQoL consistent with evidence from high-income settings.
J. Uddin, Vicky L. Joshi, M. Faruque et al.· European Journal of Preventi...· 0 citations
Systematic reviews of economic evaluations are increasingly used to inform healthcare decision making, yet approaches for a cost-effectiveness meta-analysis vary substantially, and clear methodological guidance remains limited. Differences in country income level, currency, cost reference year, analytic perspective, ti...
R. Collet, J. V. van Dongen, O. Pattanaprateep et al.· PharmacoEconomics (Auckland)· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
